These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1655470)

  • 21. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
    Yoburn BC; Nunes FA; Adler B; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):132-5. PubMed ID: 3020228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of opioid receptor density in morphine tolerance.
    Lutfy K; Yoburn BC
    J Pharmacol Exp Ther; 1991 Feb; 256(2):575-80. PubMed ID: 1847202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    Pick CG; Paul D; Pasternak GW
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    Barrett AC; Smith ES; Picker MJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment.
    Gauthier CA; Gerak LR; Bagley JR; Brockunier LL; France CP
    Psychopharmacology (Berl); 1998 May; 137(1):67-73. PubMed ID: 9631958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid receptor upregulation and supersensitivity in mice: effect of morphine sensitivity.
    Yoburn BC; Kreuscher SP; Inturrisi CE; Sierra V
    Pharmacol Biochem Behav; 1989 Mar; 32(3):727-31. PubMed ID: 2544906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unequal opiate cross-tolerance to morphine in the locomotor-activation model in the mouse.
    Brase DA
    Neuropharmacology; 1986 Mar; 25(3):297-304. PubMed ID: 2871515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).
    Ward SJ; Fries DS; Larson DL; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1985 Jan; 107(3):323-30. PubMed ID: 2984010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew).
    Rudd JA; Cheng CH; Naylor RJ; Ngan MP; Wai MK
    Eur J Pharmacol; 1999 Jun; 374(1):77-84. PubMed ID: 10422643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors.
    Pasternak GW
    Neurology; 1981 Oct; 31(10):1311-5. PubMed ID: 6287349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.